14 October, 2024Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
23 September, 2024Sensorion reports new positive clinical results presented at the World Congress of Audiology
12 September, 2024F2G announces $100 million financing to advance late-stage development and commercialization of novel antifungal drug candidate Olorofim in the US
2 September, 2024Asahi Kasei completes the recommended public cash offer and becomes the owner of 93.30 per cent of all shares in Calliditas